Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Why I think SVA is a good speculation
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Post by Stockfshron Jan 24, 2022 5:32pm
358 Views
Post# 34355551

Why I think SVA is a good speculation

Why I think SVA is a good speculation

Pouch: No fibrosis; donor cells work for two T1D patients so far

Cell strategy: Currently - donor cells; Better - Potential use of stem cells

Immune suppression strategy: Currently - drugs; Better? - Potential use of conformal coating through collaboration with University of Miami; Best? - Potential blue sky using AgeX UniverCyte gene editing
Confidential collaboration agreements with multiple pharmaceutical industry leaders
Potential competitors are stumbling making SVA more attractive: SANA, Sigilon
Huge diabetes T1D market. Additional potential markets: Hemophilia A; Thyroid disease. Tip of the iceberg?
Multiple shots on goal; steady progress.
Great management with proven individual success histories
Stock price recently shot up to $2.24 on hopes of a partnership deal on the anniversary of the last big news of collaborations. Imagine what could happen with actual news....
Thoughts?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities